2+ transients of rat cardiomyocytes, were investigated via patch-clamp technique and the Ion Optix system. The 6-Gin decreased the I Ca-L of normal and ischemic ventricular myocytes by 58.17 ± 1.05% and 55.22 ± 1.34%, respectively. 6-Gin decreased I Ca-L in a concentration-dependent manner with a halfmaximal inhibitory concentration (IC 50 ) of 31.25 μmol/L. At 300 μmol/L, 6-Gin reduced the cell shortening by 48.87 ± 5.44% and the transients by 42.5 ± 9.79%.
The results indicate that the molecular mechanisms underlying the cardio-protective effects of 6-Gin may because of a decreasing of intracellular Ca 2+ via the inhibition of I Ca-L and contractility in rat cardiomyocytes.
K E Y W O R D S
6-Gingerol, Ca 2+ transients, cardiomyocytes, contractility, L-type Ca 2+ current & Farombi, 2018; Dugasani et al., 2010; Kim et al., 2005; Kiuchi, Iwakami, Shibuya, Hanaoka, & Sankawa, 1992; Lee et al., 2018; Lee, Seo, Kang, & Kim, 2008; Lv et al., 2018; Suekawa et al., 1984; Tahir et al., 2015) .
External Ca 2+ enters the cell by passing through calcium channels. Ca 2+ can also be released from internal Ca 2+ stores including the endoplasmic reticulum (ER) or sarcoplasmic reticulum (SR) (Berridge, 1993; Clapham, 1995) . This area houses protein synthesis and transport to membranous networks. The Ca 2+ mainly enters through L-type Ca 2+ channels (LTCCs), which are essential to cardiac excitability and excitation-contraction coupling (Ferrier & Howlett, 2001 ).
In cardiacmyocyte, Ca 2+ activates the ryanodine receptor (RYR2) to create the "spark" triggering contraction. Contractility is related to intracellular Ca 2+ ([Ca 2+ ] i ) and the sensitivity of myofilaments to Ca 2+ .
There is ample evidence that excess Ca 2+ can produce pathological changes in cardiac tissue (Grinwald, 1982; Harding & Poole-Wilson, 1980; Sharma, Saffitz, Lee, Sobel, & Corr, 1983; Shen & Jennings, 1972 ) such as increased contractility, hypertrophy (Frey & Olson, 2003) , and apoptosis . In addition, the increased contractility of cardiomyocyte can lead to ischemic myocardial diseases (Gao et al., 2014) .
L-type Ca 2+ channels are related to Ca 2+ influx (Liu et al., 2016) .
Therefore, LTCCs blockers generally protect against myocardial ischemic injury via the inhibition of calcium channels. Previous studies have emphasized the inhibitory effect of verapamil (VER) on myocardial contraction and the protective effect on excess calcium overload (Song et al., 2017) . Hence, drugs that can weaken I Ca-L are promising for myocardial protection (Song et al., 2016) .
Recent reports have detailed the cardio-protective effect of 6-Gin against ischemia-reperfusion injury in rats (Lv et al., 2018);  however, the precise mechanism underlying the cellular Ca 2+ homeostasis remains poorly understood. 
| MATERIAL AND ME THOD

| Chemicals
6-Gin was purchased from Yuanye Biotechnology Co., Ltd (China).
Type Ⅱcollagenase was bought from Worthington Biochemical Corporation (USA). VER was from Hefeng Pharmaceutical Co., Ltd.
(China). Other chemicals and reagents were acquired from Sigma (USA) and were of analytical grade.
| Animals
Male Sprague-Dawley rats (180-220 g) were from the National Experimental Animal Center of Hebei, National Science Council.
They were housed in cages at a constant temperature of 25 ± 1°C
and supplied with food and water (approval number: 1803064; approval date: March 7, 2018).
| Isolation of ventricular myocytes
Rat ventricular myocytes were isolated via Mitra and Morad (Mitra & Morad, 1985) . Briefly, rats were injected with heparin (1,500 IU/ kg, i.p.) and anesthetized with sodium urethane (40 mg/kg, i.p.).
The hearts were then quickly excised and perfused at 6 ml/min Rats were injected with vasopressin via tail vein (1.5 IU/kg, i.v.) to induce cardiac ischemia (Li et al., 2014) . After 10 min of ischemia, the heart was removed as above to isolate normal rat ventricular myocytes.
| Measurement of I Ca-L
The Ca 2+ -current was recorded via the whole cell patch-clamp10.0 software using an Axon patch 200B amplifier (Axon Instrument, F I G U R E 1 Chemical structure of 6-Gin 
| Measurement of contractility
The contractions of ventricular myocytes were recorded with a videobased edge-detection system (Ion Optix, USA). Cells were placed on the stage of inverted microscope, and contractility was induced at a frequency of 0.5 Hz. Clear myocytes were selected to measure contractions.
| Measurement of Ca 2+ transients
Fura-2/AM (1 mmol/L) was fitted with a 340 or 380 nm optical filter and used to study ventricular myocyte [Ca 2+ ] i dynamics and associated myocyte contractile function. Ventricular myocyte was loaded with the fluorescent dye in the dark and measured with a fluorescence system (Ion Optix). The contractility of the myocytes was stimulated with a 0.5 Hz field.
| Data analysis
The results were presented as mean ± SEM. Comparisons were analyzed via one-way analysis of variance (ANOVA) followed by the Student's t test using Origin Pro version 9.1 software. p < 0.05 was considered to be statistically significant.
| RE SULTS
| Confirmation of I Ca-L
Verapamil (10 μmol/L) is a specific I Ca-L blocker and nearly completely stopped current flow (p < 0.01) (Figure 2 ), indicating that the L-type channels are functional in cardiomyocytes. The inhibition rates of 6-Gin at 3, 10, 30, 100, and 300 μmol/L were 8.71 ± 0.60%, 16.2 ± 0.8%, 32.67 ± 0.76%, 54.33 ± 1.89%, and 58.17 ± 1.04%, respectively (Figure 3i ). (c) Summary data of contractility before and after treatment of 300 μmol/L 6-Gin. Data are expressed as means ± SEM (n = 6-8 cells). **p < 0.01, versus control Figure 4a shows the current-voltage relationship curves for different concentrations of 6-Gin (3, 30, and 300 μmol/L) and VER (10 μmol/L). Figure 5b shows the current generated from −60 to 60 mV. Nevertheless, the I-V relationship and reversal potential of I Ca-L did not change significantly. Figure 5 shows the effects of 6-Gin concentrations (3, 30 and 300 μmol/L) on steady-state activation and inactivation of I Ca-L .
| Effects of 6-Gin on I-V relationship of I Ca-L
| Effects of 6-Gin on steady-state activation and inactivation of I Ca-L
The V 1/2 value for activation of 3, 30, and 300 μmol/L 6-Gin was −6.54 ± 0.28 mV/6.70 ± 0.24, −6.66 ± 0.28 mV/6.78 ± 0.25, −6.14 ± 0.29 mV/6.96 ± 0.26, and −6.44 ± 0.28 mV/6.71 ± 0.25, respectively. The V 1/2 value for inactivation of 0, 3, 30, and 300 μmol/L 6-Gin was −17.78 ± 1.17 mV/7.44 ± 0.98, −18.80 ± 1.22 mV/8.01 ± 1.06, and −17.81 ± 1.06 mV/7.08 ± 0.09, −2,046 ± 1.11 mV/7.89 ± 0.99, respectively.
| Effects of 6-Gin on Ca 2+ contractility
Changes in the 6-Gin on myocyte shortening are shown in Figure 6 .
6-Gin (300 μmol/L) significantly inhibited myocyte shortening by 48.87 ± 5.44%. The contractility recovered partially after washing out.
| Effects of 6-Gin on transients
The changes of the 6-Gin on Ca 2+ transients are shown in Figure 7 .
The 6-Gin (300 μmol/L) significantly inhibited the Ca 2+ transients by 42.5 ± 9.79%. The transients partially recovered partially after washing.
F I G U R E 7
Effects of 6-Gin on Ca 
| Effects of 6-Gin on contractile and relaxation function
The time to 50% of the peak (Tp) describes the speed of myocyte shortening or Ca 2+ elevation, the time to 50% of the baseline (Tr) is a parameter of cellular relaxation or Ca 2+ reuptake. 6-Gin at 300 μmol/L decreased the Tp and Tr (p < 0.05) (Figure 8 ). Also, 6-Gin at 300 μmol/L decreased the maximum velocity of contraction-relaxation (±dL/dt) (p < 0.05 or p < 0.01) (Figure 8 ).
| D ISCUSS I ON
Ginger is a food and traditional medicine used for centuries. 6-Gin is a major active ingredient in ginger and possesses a variety of interesting pharmacological effects. However, the molecular mechanisms of 6-Gin on cardio-protection have yet been reported to the best of our knowledge. This work reports intracellular I Ca-L , contractility, and Ca 2+ transients in isolated rat ventricular myocytes to detail the molecular mechanisms of 6-Gin underlying its cardio-protective effects.
The isolated myocyte model provides a specific opportunity to observe physiological adaptations of cardiac function. Calcium is a ubiquitous signal that is responsible for a broad range of cell activities (Berridge, Bootman, & Roderick, 2003; Clapham, 2007) . Ca 2+ is rapidly removed from the cytoplasm via pumps (Pozzan, Rizzuto, Volpe, & Meldolesi, 1994) and exchangers (Blaustein & Lederer, 1999) , for example, the Ca 2+ -ATPase pumps and Na + /Ca 2+ exchangers. This is then reported via signals. Internal calcium stores are held in the ER or SR membrane systems of muscle cells (Berridge, Lipp, & Bootman, 2000) . Calcium ion release is then controlled by various channels including the inositol-1, 4, 5-trisphosphate receptor (InsP3R) and ryanodine receptor (RYR) families (Berridge, 1993; Clapham, 1995) . Ca 2+ passing through the calcium channel is important for cardiac electrical activity and the excitation-contraction coupling of cardiac muscle. The principal activator of these channels is Ca 2+ itself.
There is a depolarizing current when calcium ions flow into cells (Fabiato, 1983) states that the release of calcium from the SR is not only promoted by a rapid elevation of the Ca ] i . Myocardial contractility was trigged mainly by cytosolic calcium ions entry through calcium channels (Blaustein & Lederer, 1999) , which can mediate excitation-contraction coupling.
Cardiac muscle is activated by the depolarization-dependent Ca 2+ current and the release of calcium from SR that elevates myoplasmic calcium and allows the myofilaments to contract (Atwater, Rojas, & Vergara, 1974 Our data suggest that 6-Gin reduces the I Ca-L (Figure 3 ) in a concentration-dependent manner with an IC 50 of 31.25 μmol/L in cardiomyocytes. Figure 4 shows that the I-V relationship or the reversal potential of I Ca-L did not change. Furthermore, the contractility and Ca 2+ transients were inhibited by 6-Gin (Figures 6 and 7 ).
Also, 6-Gin at 300 μmol/L reduced the I Ca-L in ischemic ventricular myocytes (Figure 3d -f). Ischemia causes membrane depolarization, calcium influx in ischemic cells is increased. Elevated intracellular calcium accelerates the activity of several ATP-consuming enzymes, which further depletes already marginal cellular energy stores, making the heart even more susceptible to ischemic damage (Undrovinas & Maltsev, 1998) . Our data suggest that 6-Gin could inhibit the increase in [Ca 2+ ] i via decreasing the extracellular Ca 2+ influx. Excitation-contraction coupling in all cardiac cells requires Ca 2+ influx, therefore the inhibitory effects of 6-Gin on contractility may through the reduction on Ca 2+ influx. Collectively, these results detail the cardio-protective effects of 6-Gin on rat ventricular myocytes as well as and its cellular mechanism.
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CO N FLI C T O F I NTE R E S T
The authors declare no conflict of interest.
E TH I C A L S TATEM ENT
All animal care and experimental protocols were ethically reviewed and approved by the Ethics Committee of Hebei University of Chinese Medicine.
O RCI D
Li Chu https://orcid.org/0000-0003-4555-8721
